Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

@article{Moreira2013InfectiousCA,
  title={Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls},
  author={Jonathan Moreira and Kari G. Rabe and James R. Cerhan and Neil E Kay and John Wilson and Timothy G. Call and Jose F. Leis and Diane F. Jelinek and Susan M. Schwager and Deborah A Bowen and Curtis A. Hanson and Susan L. Slager and Tait D Shanafelt},
  journal={Leukemia},
  year={2013},
  volume={27},
  pages={136-141}
}
Although the risk of progression from monoclonal B-cell lymphocytosis (MBL) to chronic lymphocytic leukemia (CLL) has been well characterized, it is unknown whether other common complications associated with CLL, such as increased risk of infection, occurs in individuals with MBL. We used the Mayo CLL database to identify cohorts of individuals with newly diagnosed MBL (n=154) or newly diagnosed CLL (n=174) who resided within 50 miles of Mayo Clinic. A cohort of 689 adult patients seen for a… CONTINUE READING